Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Clinical Findings and Follow-Up of 46,XY and 45,X/46,XY Testicular Dysgenesis

  • Juliana G.R. Andrade
  • , Helena Fabbri-Scallet
  • , Ana P. Dos Santos
  • , Martine Cools
  • , Ralf Werner
  • , Olaf Hiort
  • , Maricilda P. De Mello
  • , Gil Guerra-Júnior
  • , Andrea T. Maciel-Guerra*
  • *Korrespondierende/r Autor/-in für diese Arbeit
  • State University of Campinas (Unicamp)
  • Ghent University

Abstract

Historically, the terms partial (PGD) and mixed gonadal dysgenesis (MGD) have been used to describe incomplete testicular differentiation in individuals with 46,XY or 45,X/46,XY karyotypes, respectively. However, it is currently unclear to what extent clinical features actually differ between these individuals. The aim of this study was to compare clinical, laboratory, and histological findings in these 2 groups. Patients with testicular dysgenesis seen in our service between 1989 and 2013 were selected. Sixty-one patients met the inclusion criteria. Individuals with 46,XY and 45,X/46,XY karyotypes were compared regarding genital features, gonadal histology and function, growth, and associated conditions. Twenty-five had mosaicism with a 45,X cell line (MGD), while a 46,XY karyotype (PGD) was found in 36 cases belonging to 32 families. Mutations in NR5A1, WT1, and SRY genes associated with testicular dysgenesis were found in 12 families. There were no significant differences regarding parental consanguinity, degree of external androgenization, gonadal location, histology, and function, and associated conditions. However, in the MGD group, the presence of a uterus, lower birth weight and length, and short stature were more often observed. Therefore, the use of histological features to classify PDG and MGD should be abandoned and replaced by classification based on karyotype.

OriginalspracheEnglisch
ZeitschriftSexual Development
Jahrgang13
Ausgabenummer4
Seiten (von - bis)171-177
Seitenumfang7
ISSN1661-5425
DOIs
PublikationsstatusVeröffentlicht - 01.05.2020

Fördermittel

This work was supported by the CAPES Foundation, Ministry of Education, Brazil (grant number 14799/13-8) and COST Action BM1303 (Short Term Scientific Mission – reference code COST-STSM-ECOST-STSM-BM1303-070714-046991).

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 5 – Gender Equality
    SDG 5 – Gender Equality
  3. SDG 10 – Weniger Ungleichheiten
    SDG 10 – Weniger Ungleichheiten

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

DFG-Fachsystematik

  • 2.22-17 Endokrinologie, Diabetologie, Metabolismus
  • 2.22-20 Kinder- und Jugendmedizin

Fingerprint

Untersuchen Sie die Forschungsthemen von „Clinical Findings and Follow-Up of 46,XY and 45,X/46,XY Testicular Dysgenesis“. Zusammen bilden sie einen einzigartigen Fingerprint.
  • SFB 1665: Sexdiversity - Determinanten, Bedeutungen und Implikationen der Geschlechtervielfalt in soziokulturellen, medizinischen und biologischen Kontexten

    Hiort, O. (Sprecher*in), Rehmann-Sutter, C. (Stellv. Sprecher*in, Co-Sprecher*in), Aherrahrou, R. (Projektleiter*in (PI)), Busch, H. S. (Projektleiter*in (PI)), Frielitz-Wagner, I. V. (Projektleiter*in (PI)), Göpel, W. (Projektleiter*in (PI)), Holterhus, P. M. (Projektleiter*in (PI)), Hornig, N. C. (Projektleiter*in (PI)), Hundt, J. (Projektleiter*in (PI)), Jürgensen, M. (Projektleiter*in (PI)), Kircher, M. (Projektleiter*in (PI)), König, I. R. (Projektleiter*in (PI)), Krämer, U. (Projektleiter*in (PI)), Kulle, A. E. (Projektleiter*in (PI)), Laudes, M. (Projektleiter*in (PI)), Mangold, A. K. (Projektleiter*in (PI)), Malich, L. (Projektleiter*in (PI)), Mittag, J. (Projektleiter*in (PI)), Müller, F. J. (Projektleiter*in (PI)), Nemec, B. (Projektleiter*in (PI)), Palm, K. (Projektleiter*in (PI)), Reisch, N. (Projektleiter*in (PI)), Seeger, K. (Projektleiter*in (PI)), Spielmann, M. (Projektleiter*in (PI)), Stammberger, B. (Projektleiter*in (PI)), Stoff, H. (Projektleiter*in (PI)), Hines, M. (Scientific Advisor), Huebner, A. (Scientific Advisor), Wunn, C. (Scientific Advisor), Roggemann, E. (Scientific Advisor), Herrn, R. (Scientific Advisor), Sinclair, A. (Scientific Advisor), Villa Braslavsky, P.-I. (Scientific Advisor), Balachandran, S. (Postdoctoral Fellow), Mazukatow, A. (Postdoctoral Fellow), Scholz, J. (Postdoctoral Fellow), Steinbach, X. (Postdoctoral Fellow), Taege, N. (Postdoctoral Fellow), Wagemann, S. (Postdoctoral Fellow), Alnawasreh, B. (Doktorand*in), Ambrozini, L. (Doktorand*in), Blöbaum, L. (Doktorand*in), Chandra Prakash, S. A. (Doktorand*in), Dahl, A. (Doktorand*in), Denker, S. (Doktorand*in), Döhr, K. (Doktorand*in) & Egli, L. (Doktorand*in)

    01.02.24 → …

    Projekt: DFG Verbundprojekte › DFG Sonderforschungsbereiche / Transregios (SFB/TR)

Dieses zitieren